MDDRX
Price
$8.95
Change
+$0.06 (+0.67%)
Updated
Jun 22 closing price
Net Assets
454.07M
RMEBX
Price
$62.69
Change
-$0.10 (-0.16%)
Updated
Jun 22 closing price
Net Assets
116.64B
Interact to see
Advertisement

MDDRX vs RMEBX

MDDRX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
MDDRX vs. RMEBX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDDRX is a Buy and RMEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 117B vs. MDDRX (454M). MDDRX pays higher dividends than RMEBX: MDDRX (1.26) vs RMEBX (1.04). MDDRX was incepted earlier than RMEBX: MDDRX (12 years) vs RMEBX (12 years). RMEBX (1.07) and MDDRX (1.05) have similar cost to investors . MDDRX is a more actively managed with annual turnover of: 68.00 vs. RMEBX (30.00). MDDRX has a lower initial minimum investment than RMEBX: MDDRX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 10.14 vs. MDDRX (-5.07). RMEBX return over 5 years is better than : 35.62 vs. MDDRX (-26.86).
MDDRXRMEBXMDDRX / RMEBX
Total Expense Ratio1.051.0798%
Annual Report Gross Expense Ratio1.051.0798%
Fund Existence12 years12 years-
Gain YTD11.4046.444177%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets454M117B0%
Annual Yield % from dividends1.261.04122%
Returns for 1 year-5.0710.14-50%
Returns for 3 years-12.7634.54-37%
Returns for 5 years-26.8635.62-75%
Returns for 10 years-23.9194.57-25%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE30.922.46
+8.64%
Cue Biopharma Inc.
DYN20.891.09
+5.51%
Dyne Therapeutics
AMKR93.553.09
+3.42%
Amkor Technology
APM0.860.03
+3.35%
Aptorum Group Limited
FWRG11.55-0.26
-2.20%
First Watch Restaurant Group